Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:SMWB
NYSE:SMWBSoftware

Assessing Similarweb (SMWB) Valuation After Launch Of AI Studio Enterprise Intelligence Platform

Similarweb (SMWB) has drawn fresh attention after launching AI Studio, an enterprise AI intelligence platform that lets clients query its extensive digital data through conversational research, deep reports, and auto generated dashboards for business decision support. See our latest analysis for Similarweb. The AI Studio launch and Bloomberg Terminal integration arrive during a weak patch for the stock, with Similarweb’s 30 day share price return of 39.16% and year to date share price return...
NasdaqGS:NCNO
NasdaqGS:NCNOSoftware

Is nCino (NCNO) Quietly Redefining Its Moat With Embedded Insurance Partnerships?

Matic recently announced a partnership with nCino to embed its home insurance marketplace directly into nCino’s mortgage point of sale platform, allowing borrowers to shop for coverage within the digital loan process. This integration extends nCino’s mortgage workflow into adjacent insurance services, potentially making its platform more valuable to both lenders and borrowers. Next, we’ll examine how embedding Matic’s home insurance marketplace into nCino’s mortgage platform could influence...
NasdaqGS:GLPI
NasdaqGS:GLPISpecialized REITs

A Look At Gaming And Leisure Properties (GLPI) Valuation After Recent Steady Share Performance

Why Gaming and Leisure Properties Is On Investors’ Radar Gaming and Leisure Properties (GLPI) has drawn attention after a recent stretch of steady share performance, with modest gains over the past month and past 3 months prompting a closer look at its fundamentals. See our latest analysis for Gaming and Leisure Properties. At a share price of US$46.20, Gaming and Leisure Properties has seen steady momentum build, with a 30 day share price return of 2.51% and a 5 year total shareholder return...
SWX:RSGN
SWX:RSGNElectrical

R&S Group Holding (SWX:RSGN) Valuation After New Growth Guidance And Confirmed Dividend Decision

Why R&S Group Holding’s latest guidance and dividend decision matter R&S Group Holding (SWX:RSGN) has set fresh expectations for FY2025, pairing new earnings guidance for organic net sales growth of 8 to 12% over the cycle with a confirmed proposed dividend of CHF 0.50 per share. For you as an investor, this combination of quantified growth ambitions and a specific cash payout level provides clearer signals on how management is thinking about balancing reinvestment in the business with direct...
BIT:SPM
BIT:SPMEnergy Services

Assessing Saipem (BIT:SPM) Valuation After New ISPRA Underwater Vehicle Contract

Saipem (BIT:SPM) has attracted fresh attention after agreeing to supply an underwater remotely operated vehicle to Italy's ISPRA, linking its subsea engineering expertise directly to oceanographic research and potential long term project visibility. See our latest analysis for Saipem. The ISPRA contract lands at a time when Saipem’s share price has a 30 day return of 21.73% and a 90 day return of 43.87%, with 1 year total shareholder return of 54.62% pointing to strong recent momentum after a...
NasdaqGM:AAOI
NasdaqGM:AAOICommunications

A Look At Applied Optoelectronics (AAOI) Valuation After Its US$300 Million Sugar Land Expansion Plan

Applied Optoelectronics (AAOI) has broken ground on a new 210,000 square foot manufacturing facility in Sugar Land, Texas, and has doubled its planned investment in the site to US$300 million to support data center demand. See our latest analysis for Applied Optoelectronics. The new Sugar Land expansion comes after a sharp run in the share price. The 90 day share price return is 104.94% and the 3 year total shareholder return is very large. This suggests momentum has been strong even after a...
NYSE:CAVA
NYSE:CAVAHospitality

Is It Time To Reconsider CAVA Group (CAVA) After A 51.3% One Year Share Price Slide

If you are trying to figure out whether CAVA Group's share price lines up with its fundamentals, the valuation story is where things start to get interesting. The stock last closed at US$63.61, with a 7 day return of a 1.5% decline, a 30 day return of a 7.2% decline, a year to date return of 5.1% and a 1 year return of a 51.3% decline, which may catch the eye of investors thinking about potential upside or changing risk. Recent coverage around CAVA Group has mainly focused on its position...
TSE:2270
TSE:2270Food

What MEGMILK SNOW BRAND (TSE:2270)'s Nine-Month 2026 Earnings Call Commentary Means For Shareholders

MEGMILK SNOW BRAND Co., Ltd. recently held its nine months 2026 earnings call on February 13, 2026, updating investors on the company’s latest financial and operational performance. The call offered fresh detail on how management is executing its current business plan and responding to recent industry conditions, providing investors with new context for assessing the company. We’ll now examine how the earnings call’s updated management commentary may influence MEGMILK SNOW BRAND’s broader...
NYSE:STT
NYSE:STTCapital Markets

State Street Expands Fee Businesses With New ETF And Mariner Deal

State Street (NYSE:STT) has launched a new actively managed Prime Money Market ETF, targeting investors who want exchange traded access to cash management. The company has also reached a wealth management technology agreement with Mariner, which will use State Street's Charles River platform. Together, these moves expand State Street's product shelf and deepen its role as a technology partner for financial advisors. For you as an investor, this combination of a new Prime Money Market ETF...
NYSE:RCL
NYSE:RCLHospitality

Royal Caribbean Beach Club And Higher Dividend Recast Cash Flow Story

Royal Caribbean Cruises (NYSE:RCL) announced its first stand-alone Royal Beach Club, expanding its leisure offerings beyond ships. The company also reported a higher quarterly dividend, indicating a change in its shareholder payout level. Both updates were recently communicated as part of Royal Caribbean's ongoing product and capital allocation plans. Royal Caribbean operates one of the largest global cruise brands, with revenue tied to ticket sales and onboard spending. The new beach club...
NasdaqGS:PRAX
NasdaqGS:PRAXBiotechs

Praxis Precision Medicines (PRAX) Valuation After Analyst Upgrades And Key Breakthrough Therapy NDA Plans

Why Praxis Precision Medicines stock is back on investors’ radar Praxis Precision Medicines (PRAX) has drawn fresh attention after multiple analysts expressed confidence in its lead drug candidates, alongside upcoming NDA submissions for ulixacaltamide and relutrigine, both with Breakthrough Therapy Designation. See our latest analysis for Praxis Precision Medicines. The recent 2.98% 1 day share price return and 18.55% 30 day share price return, on top of a 1 year total shareholder return of...
NasdaqGS:OZK
NasdaqGS:OZKBanks

A Look At Bank OZK (OZK) Valuation As Recent Price Moves Contrast With Mixed Long Term Returns

Bank OZK stock snapshot after recent movement Bank OZK (OZK) shares recently closed at $48.88. The 1 day and 7 day returns are slightly negative, while the stock shows gains over the past month, past 3 months and year to date. See our latest analysis for Bank OZK. The recent 1 day share price return of 0.75% and 7 day share price return of 2.02% follow stronger gains, with a 30 day share price return of 5.10% and a 90 day share price return of 10.84%. However, the 1 year total shareholder...
NYSE:BMY
NYSE:BMYPharmaceuticals

Bristol-Myers Squibb Earnings Strength And Pipeline Shape Future Valuation

Bristol-Myers Squibb (NYSE:BMY) reported strong fourth quarter earnings, supported by a growth portfolio that includes several products now generating more than $1b in annual sales. The company highlighted upcoming pivotal pipeline readouts that could influence its future product mix and long term revenue profile. Bristol-Myers Squibb announced recent business moves, including the acquisition of Orbital Therapeutics, a collaboration with BioNTech, and plans for a new research facility. These...
NYSE:SYF
NYSE:SYFConsumer Finance

Is Synchrony Financial (SYF) Offering An Opportunity After Recent Share Price Pullback?

If you are wondering whether Synchrony Financial's current share price reflects its true worth, you are not alone. This article is built to help you size that up. The stock closed at US$71.11, with returns of a 3.9% decline over 7 days, an 8.9% decline over 30 days, a 16.0% decline year to date, but a 13.0% gain over 1 year, 113.4% over 3 years and 117.1% over 5 years. Recent price moves sit against a backdrop of ongoing focus on consumer credit trends, funding costs and card spending...
NasdaqCM:BTDR
NasdaqCM:BTDRSoftware

Bitdeer Technologies Group (BTDR) Q3 Loss Deepens And Tests Bullish Profitability Narratives

Bitdeer Technologies Group (NasdaqCM:BTDR) just posted its FY 2025 third quarter numbers with revenue of US$169.7 million, a basic EPS loss of US$1.28 per share and net income loss of US$266.7 million, putting profitability firmly in focus for investors. The company has seen quarterly revenue move from US$70.1 million in Q1 2025 and US$155.6 million in Q2 2025 to US$169.7 million in Q3. Over the same period, EPS moved from a profit of US$2.15 in Q1 to losses of US$0.76 and US$1.28 in Q2 and...
NYSE:GLP
NYSE:GLPOil and Gas

Did Global Partners' (GLP) Higher Quarterly Payout Just Recast Its Income-Focused Investment Narrative?

Global Partners LP recently declared a cash distribution of US$0.7600 per unit (US$3.04 on an annualized basis) for the October–December 2025 period, payable on February 13, 2026 to unitholders of record as of February 9, 2026, and scheduled its fourth-quarter and full-year 2025 results release for February 27, 2026. This distribution decision, coming just ahead of the upcoming earnings release, highlights management’s current capital return priorities and income profile for...
NYSE:ATGE
NYSE:ATGEConsumer Services

Covista Rebrand And AI Credentials Target Healthcare Workforce Demand

Covista, formerly Adtalem Global Education, has announced a corporate rebrand. The company has partnered with Google Cloud to launch AI credential programs for healthcare professionals. The rebrand and partnership highlight a sharpened focus on technology enabled healthcare education. These developments are material for Covista's positioning as a healthcare workforce education provider on the NYSE:ATGE. For you as an investor, the Covista rebrand and its work with Google Cloud point to a...
SEHK:3738
SEHK:3738Software

Vobile Group (SEHK:3738) Valuation Check After Finloop IP Tokenization Collaboration

Vobile Group (SEHK:3738) has drawn fresh attention after announcing a collaboration with Finloop Finance Technology to tokenize offshore real world assets tied to cultural and creative intellectual property, with the aim of building a compliant IP backed digital asset ecosystem. See our latest analysis for Vobile Group. The Finloop agreement lands at a time when momentum in Vobile Group’s shares has been picking up, with a 7 day share price return of 37.09% and a year to date share price...
NYSE:TDW
NYSE:TDWEnergy Services

Why Tidewater (TDW) Is Up 6.7% After New 2026 Outlook and Buyback Update

Tidewater recently issued 2026 revenue guidance of US$1.32 billion to US$1.37 billion, reaffirmed vessel utilization near 76%, and left about US$500 million remaining under its share repurchase authorization, while Sagil Capital fully exited its position in the stock. At the same time, Black Bear Value Fund reiterated Tidewater as a key holding, highlighting the company’s sizeable offshore support vessel fleet, reduced debt, and capital return plans as reasons for its continued interest...
NYSE:IQV
NYSE:IQVLife Sciences

IQVIA And Duke Partnership Highlights Obesity Focus Amid Share Price Weakness

IQVIA Holdings (NYSE:IQV) has entered a collaboration with the Duke Clinical Research Institute to advance clinical research in obesity and cardiometabolic trials. The partnership focuses on complex clinical programs and aims to broaden access to diverse patient groups in areas of rising healthcare focus. For investors watching IQVIA Holdings at a share price of $168.85, this new collaboration sits against a backdrop of weak recent returns. The stock has declined 6.7% over the past week,...
NasdaqGS:ZBIO
NasdaqGS:ZBIOBiotechs

Assessing Zenas BioPharma (ZBIO) Valuation After Positive MoonStone Phase 2 Results In Multiple Sclerosis

MoonStone Phase 2 data and why it matters for Zenas BioPharma (ZBIO) Zenas BioPharma (ZBIO) is in the spotlight after presenting Phase 2 MoonStone trial results for obexelimab in relapsing multiple sclerosis. The drug met its primary endpoint with a highly statistically significant reduction in new active brain lesions. For investors watching ZBIO, the detailed 24 week dataset, together with the late breaking presentation at the ACTRIMS Forum 2026, raises fresh questions about how this...
NYSE:SAFE
NYSE:SAFESpecialized REITs

Safehold Targets Value Unlock After S&P Upgrade And Buyback Launch

Safehold (NYSE:SAFE) received an S&P credit rating upgrade to A- with a stable outlook. The company announced a share buyback program alongside plans to monetize more of its unrealized capital appreciation, known as "Carats." Management outlined an expansion of ground lease originations, including a focus on affordable housing and broader geographic reach. Safehold, trading at $14.84, is working to reposition itself in the eyes of both credit markets and equity investors. The stock is up...
NYSE:CTOS
NYSE:CTOSTrade Distributors

Assessing Custom Truck One Source’s Valuation After The Hiab Partnership Expands Its U.S. Reach

What the Hiab partnership could mean for Custom Truck One Source The new dealer agreement between Hiab and Custom Truck One Source (CTOS) expands sales and service coverage for HIAB cranes and MOFFETT forklifts across Western and Northeastern states, providing investors with an additional data point on the company’s growth ambitions. See our latest analysis for Custom Truck One Source. Recent news around the Hiab agreement sits alongside strong share price momentum, with a 22.3% 90 day share...
OM:CAMX
OM:CAMXPharmaceuticals

Why Camurus (OM:CAMX) Is Down 24.8% After Lifting 2026 Guidance and Showcasing Oxyesa Progress

Camurus AB reported its fourth-quarter and full-year 2025 results, with full-year sales rising to SEK 2,265.38 million and net income to SEK 735.57 million, while issuing 2026 guidance for revenues of SEK 2.60–2.90 billion and operating result of SEK 0.90–1.20 billion. Alongside these results, Camurus highlighted 2025 milestones including EU and UK approvals for Oxyesa in acromegaly and progress in long-acting metabolic therapies, underlining how its product pipeline and regulatory traction...